Syros Pharmaceuticals (SYRS)

Syros Pharmaceuticals (SYRS) Balance Sheet


Syros Pharmaceuticals Balance Sheet

Syros Pharmaceuticals's total assets for Q4 2022 were $244.49M, a decrease of -14.13% from the previous quarter. SYRS total liabilities were $116.75M for the fiscal quarter, a -24.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 244.49M$ 182.94M$ 213.25M$ 149.98M$ 106.77M
Total Liabilities
$ 116.75M$ 97.72M$ 122.70M$ 70.79M$ 28.18M
Total Equity Gross Minority
$ 127.74M$ 85.22M$ 90.55M$ 79.18M$ 78.59M
Total Capitalization
$ 168.38M$ 125.47M$ 130.10M$ 79.18M$ 78.59M
Preferred Stock Equity
Capital Lease Obligations
$ 22.92M$ 24.93M$ 26.66M$ 25.92M$ 31.00K
Currency in USD

Syros Pharmaceuticals Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis